Rating Change
Canaccord Genuity reiterated its Hold rating on Repligen Corporation (NASDAQ:RGEN) on October 19, 2026.
reiterateNASDAQ:RGEN
Canaccord Genuity Reiterates Hold Rating on Repligen Corporation (RGEN)
Canaccord Genuity reiterated its Hold rating on Repligen Corporation (NASDAQ:RGEN) on October 19, 2026.
At publication ·
What changed
Repligen Corporation (NASDAQ:RGEN) · reiterate
- Firm
- Canaccord Genuity
- Rating
- Hold to Hold
- Price at event
- $176.43
- Market capitalization
- $9.1B
At a glance
Key takeaways
- Canaccord Genuity maintained a Hold rating on Repligen Corporation (RGEN) on October 19, 2026, while nine of the ten most recent analyst ratings are Buy or Overweight.
Market Context
Repligen Corporation operates in the Healthcare sector. The stock currently trades at $176.43 with a market capitalization of $9.1B. The stock has gained 11.4% over the past 52 weeks.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Repligen Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Repligen Corporation
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 19, 2026 | Canaccord Genuity | Hold | N/A |
| Oct 07, 2026 | Barclays | Overweight | N/A |
| Sep 09, 2026 | UBS | Buy | N/A |
| Jul 30, 2026 | Wells Fargo | Overweight | N/A |
| Jul 29, 2026 | JP Morgan | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View RGEN Stock Page
Frequently Asked Questions
What does the Hold rating mean for RGEN?
A rating of Hold from Canaccord Genuity reflects the analyst's outlook on Repligen Corporation (NASDAQ:RGEN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RGEN forecast page.